JOINT FILING AGREEMENTJoint Filing Agreement • December 21st, 2015 • Soon-Shiong Patrick • Services-commercial physical & biological research
This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute but one agreement.
CERTIFICATION AND AGREEMENTCertification and Agreement • December 21st, 2015 • Soon-Shiong Patrick • Services-commercial physical & biological research • California
THIS CERTIFICATION AND AGREEMENT (this “Agreement”) is dated this 17th day of December, 2015 (the “Effective Date”), by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Company”), Patrick Soon-Shiong, M.D. (“Soon-Shiong”), CAMBRIDGE EQUITIES, LP (the “Cambridge”), MP 13 Ventures, LLC (“MP 13”), and CHAN SOON-SHIONG FAMILY FOUNDATION (the “Foundation”). Soon-Shiong, Cambridge, MP 13 and the Foundation are referred to herein collectively as the “Soon-Shiong Affiliates”.
